Please login to the form below

Not currently logged in
Email:
Password:

Senior changes at Merck KGaA

New head of controlling for its healthcare business

Merck KGaA, Andreas Stickler Germany's Merck KGaA has announced changes to its senior financial team for its healthcare operations.

Andreas Stickler (pictured top right) has been appointed as new head of controlling of the healthcare business sector where he will be responsible for the operations of Merck's pharma division Merck Serono, its consumer health business, biosmilars and allergy subsidiary Allergopharma.

Stickler is a 12-year veteran of Merck and has been head of mergers and acquisitions since 2008, leading the takeover of Millipore in 2010. He previously worked at Degussa, Aventis and Hoechst.

Merck 
KGaA, Roman WerthAnother Merck employee Roman Morten Werth (pictured bottom right) will assume Stickler's former position as head of mergers and acquisitions, a department he has been part of since joining Merck in 2008. He was previously manager of mergers and acquisitions for technology firm Siemens.

Merck's chief financial officer Marcus Kuhnert said: “We're delighted that two key positions in our finance function will be filled with internal managers who bring the experience and the track record to ensure quality and continuity alike.”

 

2nd February 2015

From: PME

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics